#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma Thermal burn Ewing's sarcoma Follicular lymphoma stage I Acute leukaemia Transplant rejection Polymyositis Familial hypertriglyceridaemia Ataxia telangiectasia Hairy cell leukaemia recurrent Eosinophilic oesophagitis Neoplasm Pseudomyxoma peritonei Thromboangiitis obliterans Mycobacterium abscessus infection More trials…

    Learn about Rare Diseases

    Brain stem glioma – Trials in Disease Undifferentiated sarcoma – Trials in Disease Familial amyotrophic lateral sclerosis – Life with Disease Methylmalonic acidaemia – Treatment Breast angiosarcoma – Diagnostics Biotinidase deficiency Nodal marginal zone B-cell lymphoma – Treatment Haemophilia B without inhibitors Advanced systemic mastocytosis – Basic Information Ewing’s sarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cobolimab Micafungin Levofloxacin Hemihydrate Omx-0407 Tofersen Cl-Ad-Msc-002 Oregovomab Cevostamab Human Coagulation Factor Viii Dapagliflozin Diphenhydramine Hydrochloride Gad20-209-Fsp-A4 Magnesium Oxybate GSKVX000000025896 Amantadine Hydrochloride A/H1N1 INFLUENZA VACCINE ICEF15 Tazemetostat Pramlintide Acetate Albaconazole More therapies…

    Learn about Your Condition

    Hypersensitivity Oesophageal carcinoma Uterine cancer Cervix carcinoma stage I Acute hepatic failure Persistent depressive disorder Post-traumatic stress disorder Hypoaesthesia Rhabdoid tumour of the kidney Metabolic disorder Rhabdoid tumour Obsessive-compulsive disorder Colorectal adenocarcinoma Bladder cancer stage II Critical illness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dry eye

  • Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry eye
    • Sjogren’s syndrome
    Investigated Drugs:
    • Ianalumab
    Austria Belgium Czechia France Germany Lithuania +3

  • Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry eye
    • Sjogren’s syndrome
    Investigated Drugs:
    • Ianalumab
    Bulgaria France Germany Greece Hungary Italy +5

  • Study on Insulin Eye Drops for Treating Dry Eye in Patients Using Topical Hypotensors

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Benzalkonium Chloride
    • Hypromellose
    • Insulin Human
    Spain

  • Study on the Effectiveness and Safety of Insulin, Ciclosporin, and Benzalkonium Chloride in Patients with Moderate to Severe Dry Eye Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Benzalkonium Chloride
    • Hypromellose
    • Ciclosporin
    Spain

  • Study on the Effectiveness and Safety of Hydrocortisone Sodium Phosphate for Patients with Dry Eye and Moderate Meibomian Gland Dysfunction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Hydrocortisone Sodium Phosphate
    Spain

  • Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry eye
    • Sjogren’s syndrome
    Investigated Drugs:
    • Lamivudine
    • Entecavir
    • Ianalumab
    Austria Belgium Bulgaria Czechia France Germany +10
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!